Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Palatin Technologies Inc. (PTN)

1.03   -0.02 (-1.9%) 07-16 16:00
Open: 1.03 Pre. Close: 1.05
High: 1.04 Low: 1
Volume: 1,427,245 Market Cap: 222M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.051 - 1.056 1.056 - 1.06
Low: 0.92 - 0.925 0.925 - 0.929
Close: 1.042 - 1.05 1.05 - 1.057

Technical analysis

as of: 2019-07-16 3:23:24 PM
Stoxline posted a BUY today, downgraded from strong buy. Upward movement continues, but could change at any time.
Target: Six months: 1.69     One year: 2.08
Support: Support1: 0.91    Support2: 0.76
Resistance: Resistance1: 1.45    Resistance2: 1.78
Pivot: 1.02
Moving Average: MA(5): 0.98     MA(20): 1.09
MA(100): 1.16     MA(250): 0.98
MACD: MACD(12,26): -0.08     Signal(9): -0.08
Stochastic oscillator: %K(14,3): 18.74     %D(3): 9.82
RSI: RSI(14): 42.89
52-week: High: 1.78  Low: 0.59  Change(%):
Average Vol(K): 3-Month: 414215  10-Days: 260700

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
PTN has closed above bottom band by 48.8%. Bollinger Bands are 1.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Tue, 25 Jun 2019 21:09:35 Z
Why Palatin Technologies Stock Dropped as Much as 21.5% Today

Mon, 24 Jun 2019 20:27:08 Z
Health Care Sector Update for 06/24/2019: KRYS,PTN,AMAG,MESO,BMY,CELG

Mon, 24 Jun 2019 18:27:07 Z
Health Care Sector Update for 06/24/2019: PTN,AMAG,MESO,BMY,CELG

Mon, 24 Jun 2019 13:47:10 Z
Health Care Sector Update for 06/24/2019: PTN, AMAG, MESO, BMY, CELG, JNJ, PFE, ABT, MRK, AMGN

Tue, 04 Jun 2019 13:11:53 Z
3 Drug Stocks That Could Win From Key FDA Approvals in June

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Diagnostics Research
Shares Out. (M)
Shares Float (M) 189.47
% Held by Insiders 2.61
% Held by Institutions 20.40
Shares Short (K) 13160
Shares Short P. Month (K)

Stock Financials

EPS -0.023
EPS Est. Current Year -0.350
EPS Est. Next Year -0.060
EPS Est. Next Quarter
Forward EPS -0.080
Book Value (p.s.) 0.080
PEG Ratio
Profit Margin -22.48
Operating Margin -20.20
Return on Assets (ttm) -10.8
Return on Equity (ttm) -35.3
Qtrly Rev. Growth
Gross Profit (p.s.) 0.170
Sales Per Share
EBITDA (p.s.) -0.020
Qtrly Earnings Growth
Operating Cash Flow (M) -4.34
Levered Free Cash Flow (M) -2.65

Stock Valuations

P/E -44.35
P/E Growth Ratio -0.03
P/BV 12.75
P/S 2071211904.00

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.